Literature DB >> 16114069

Genes critical to vasculogenesis as defined by systematic analysis of vascular defects in knockout mice.

W Scott Argraves1, Christopher J Drake.   

Abstract

To identify genes important to the process of vasculogenesis, we evaluated embryonic vascular anomalies from 100 mouse knockout studies using a novel meta-analysis approach. By applying this method, termed approach for ranking of embryonic vascular anomalies (AREVA), rank scores were calculated for each knockout based on the occurrence of vascular defects during periods of vasculogenesis in specific embryonic regions. As a result, 12 genes (fibronectin, VEGFR-1/Flt-1, VEGFR-2/Flk-1, alpha 5 integrin, Tek/Tie2, VE-cadherin, VEGFA, connexin 45, ShcA, cytochrome P450 reductase, CD148/DEP-1, and EphrinB2) were determined to play critical roles in vasculogenesis. Functional categorization of these genes revealed the fundamental importance of VEGF signaling since 10 of the 12 genes (fibronectin, VEGFR-1/Flt-1, VEGFR-2/Flk-1, alpha 5 integrin, VE-cadherin, VEGFA, ShcA, cytochrome P450 reductase, CD148/DEP-1, and EphrinB2) relate to this pathway. Furthermore, the findings highlight a potential network for regulating VEGF signaling involving integration of fibronectin, EphrinB2, Tie2, and connexin 45 signaling pathways via the ShcA/Ras/Raf/Mek/Erk cascade. In addition to retrospective application of AREVA as done herein, AREVA can be used prospectively to determine the relevancy to vasculogenesis of newly inactivated genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16114069     DOI: 10.1002/ar.a.20232

Source DB:  PubMed          Journal:  Anat Rec A Discov Mol Cell Evol Biol        ISSN: 1552-4884


  24 in total

Review 1.  Current Therapeutic Options in Sturge-Weber Syndrome.

Authors:  Anne Comi
Journal:  Semin Pediatr Neurol       Date:  2015-11-11       Impact factor: 1.636

2.  The mouse KRAB zinc-finger protein CHATO is required in embryonic-derived tissues to control yolk sac and placenta morphogenesis.

Authors:  Maho Shibata; María J García-García
Journal:  Dev Biol       Date:  2010-11-19       Impact factor: 3.582

3.  Vascular sprout formation entails tissue deformations and VE-cadherin-dependent cell-autonomous motility.

Authors:  Erica D Perryn; András Czirók; Charles D Little
Journal:  Dev Biol       Date:  2007-11-04       Impact factor: 3.582

4.  Platelet-derived growth factor receptors direct vascular development independent of vascular smooth muscle cell function.

Authors:  Wendy J French; Esther E Creemers; Michelle D Tallquist
Journal:  Mol Cell Biol       Date:  2008-07-07       Impact factor: 4.272

5.  Dynamic responses of endothelial cells to changes in blood flow during vascular remodeling of the mouse yolk sac.

Authors:  Ryan S Udan; Tegy J Vadakkan; Mary E Dickinson
Journal:  Development       Date:  2013-09-04       Impact factor: 6.868

6.  Sphingosine-1-phosphate signaling in vasculogenesis and angiogenesis.

Authors:  Kelley M Argraves; Brent A Wilkerson; W Scott Argraves
Journal:  World J Biol Chem       Date:  2010-10-26

7.  NgBR is essential for endothelial cell glycosylation and vascular development.

Authors:  Eon Joo Park; Kariona A Grabińska; Ziqiang Guan; William C Sessa
Journal:  EMBO Rep       Date:  2016-01-11       Impact factor: 8.807

8.  Conformational remodeling of the fibronectin matrix selectively regulates VEGF signaling.

Authors:  Anthony Ambesi; Paula J McKeown-Longo
Journal:  J Cell Sci       Date:  2014-06-30       Impact factor: 5.285

9.  K-ras mutation status correlates with the expression of VEGFR1, VEGFR2, and PDGFRalpha in colorectal cancer.

Authors:  Carl C Schimanski; Tim Zimmermann; Irene Schmidtmann; Ines Gockel; Hauke Lang; Peter R Galle; Markus Moehler; Martin R Berger
Journal:  Int J Colorectal Dis       Date:  2009-11-20       Impact factor: 2.571

10.  Deficiency of zonula occludens-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cells.

Authors:  Tatsuya Katsuno; Kazuaki Umeda; Takeshi Matsui; Masaki Hata; Atsushi Tamura; Masahiko Itoh; Kosei Takeuchi; Toshihiko Fujimori; Yo-ichi Nabeshima; Tetsuo Noda; Shoichiro Tsukita; Sachiko Tsukita
Journal:  Mol Biol Cell       Date:  2008-03-19       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.